The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
14-Jul-11
$340 million
Target:
Edge Oilfield Services
Acquiror:
Key Energy Services, Inc.
Advised Key Energy Services, the largest onshore, rig-based well servicing contractor, on its acquisition of Edge Oilfield Services, a provider of onshore oilfield rental equipment
30-Jun-11
$609 million
Target:
Diabetes-related patent estate and royalty stream of Astellas Pharma subsidiary, Prosidion
Acquiror:
Royalty Pharma
Advised Royalty Pharma, a leading acquiror of biopharmaceutical royalty interests, on the acquisition of the DPP-IV patent estate and associated royalty stream of Astellas Pharma subsidiary, Prosidion
20-Jun-11
$2.0 billion
Target:
Capital Power Income L.P.
Acquiror:
Atlantic Power Corporation
Advised Capital Power Income L.P., a Canadian power trust with a portfolio of 20 power generation assets located in Canada and the United States (total net generating capacity of 1,400 MW), on its sale to Atlantic Power Corporation
07-Feb-11
$548 million
Target:
Wesco Financial Corporation
Acquiror:
Berkshire Hathaway Inc.
Advised the Special Committee of Wesco Financial Corporation in connection with Berkshire Hathaway Inc.'s proposal to acquire the remaining 19.9% of the shares of Wesco’s common stock that it does not presently own
04-Feb-11
$420 million
Target:
Bosque Power Company
Advised Bosque Power Company, a natural gas-fired power plant located in Texas, on its negotiations with lenders and restructuring
11-Jan-11
$220 million
Target:
Constar International, Inc.
Advised Constar International, Inc., a plastic packaging manufacturer, in connection with its pre-arranged Chapter 11 proceedings
15-Dec-10
$12.9 billion
Target:
Alcon, Inc.
Acquiror:
Novartis AG
Advised the Independent Director Committee of Alcon, Inc., an ophthalmic pharmaceutical company, on the sale of Alcon’s outstanding publicly held interest to Novartis AG, a global pharmaceutical company
15-Dec-10
$4.6 billion
Target:
Dynegy Inc.
Acquiror:
Icahn Enterprises LP
Advised Dynegy Inc., an independent power producer, on its sale to Icahn Enterprises LP in an all-cash transaction
13-Dec-10
$875 million
Target:
Electrical Products Division of A. O. Smith Corporation
Acquiror:
Regal Beloit Corporation
Advised A. O. Smith Corporation on the sale of its Electrical Products Company, a manufacturer of a comprehensive line of electric motors, to Regal Beloit Corporation, a leading manufacturer of electrical and mechanical motion control products
07-Dec-10
$500 million
Target:
Medicity, Inc.
Acquiror:
Aetna Inc.
Advised Aetna Inc. on its acquisition of Medicity, Inc., a leading provider of technology solutions to enable the secure access and exchange of healthcare information
01-Dec-10
$NA
Target:
Planar Solutions, LLC
Acquiror:
FUJIFILM Corporation
Advised Wacker Chemie AG on the sale of Wacker Chemical Corporation’s 50% equity stake in Planar Solutions LLC, a dedicated CMP slurry manufacturer, to its JV partner, FUJIFILM Corporation
10-Nov-10
$NA
Target:
Pension Benefit Guaranty Corporation
Advised the Pension Benefit Guaranty Corporation ("PBGC") in connection with its claim in Chemtura’s Chapter 11 proceeding
07-Aug-10
$220 million
Target:
Environmental Systems Products
Advised Environmental Systems Products Holdings with its out-of-court restructuring
12-Jul-10
$NA
Target:
Breast Care Business of Ethicon-Endo Surgery
Acquiror:
Devicor Medical Products, Inc. (a GTCR portfolio company)
Advised GTCR and Devicor Medical Products, Inc., a portfolio company of GTCR, on the acquisition of the Breast Care Business of Ethicon-Endo Surgery
30-Jun-10
$820 million
Target:
Trident Resources Corporation
Advised Chilton Investment Company on Trident’s financial restructuring and emergence from CCAA / Chapter 11 bankruptcy protection including the negotiation of a new equity investment
28-Jun-10
$336 million
Target:
Scott Wilson Group plc
Acquiror:
URS Corporation
Advised Scott Wilson Group plc, a LSE listed global integrated design and engineering consultancy, on its sale to URS Corporation, a global provider of engineering, construction and technical services
14-Jun-10
$82 million
Target:
Bemis Company, Inc. (certain of its recently acquired packaging assets)
Acquiror:
Exopack Holding Company
Advised Bemis Company, Inc. on the sale of certain of its recently acquired flexible packaging assets as required by the US Department of Justice as a condition to the closing of its $1.2 billion acquisition of the Alcan Packaging Food Americas business (business unit of Rio Tinto plc)
30-Apr-10
$NA
Target:
Pension Benefit Guaranty Corporation
Advised the Pension Benefit Guaranty Corporation ("PBGC") in connection with its claim in Lyondell’s Chapter 11 proceeding
26-Apr-10
$1.5 billion
Target:
Chloride Group plc
Acquiror:
Emerson Electric Co.
Advised Emerson Electric Co., a diversified global technology and industrial company, on its acquisition of Chloride Group plc, a manufacturer of uninterruptible power supply (UPS) systems
05-Apr-10
$225 million
Target:
Medegen, Inc
Acquiror:
CareFusion Corporation
Advised Medegen, Inc., a medical device company that develops, manufactures and markets clinically superior disposable intravenous therapy products on its sale to CareFusion, a global medical devices company
03-Mar-10
$NA
Target:
Puerta Mexico Transportation Facility
Acquiror:
Kansas City Southern
Advised Ports America, Inc., a portfolio company of Highstar Capital, on its sale of Puerta Mexico, a state-of-the-art customs-clearing intermodal transportation facility located in the Mexico City market
23-Feb-10
$NA
Target:
Heartscape Technologies, Inc.
Acquiror:
Roper Industries, Inc.
Advised Heartscape Technologies, a medical device company on its sale of substantially all its assets to Roper Industries, a diversified growth company
20-Dec-09
$1.3 billion
Target:
Mining Division of Terex Corp.
Acquiror:
Bucyrus International
Advised Bucyrus International, Inc., a global mining equipment manufacturer, on the acquisition of the mining division of Terex Corp., a diversified equipment company
09-Nov-09
$327 million
Target:
Enzon Pharmaceuticals, Inc.
Acquiror:
Sigma-Tau Pharmaceuticals
Advised Enzon Pharmaceuticals, Inc., a biopharmaceutical company on the sale of its specialty pharmaceutical business to Sigma-Tau, an Italian pharmaceutical company
27-Oct-09
$325 million
Target:
Fleetwood Enterprises, Inc.
Acquiror:
Various
Advised Fleetwood Enterprises, Inc. on the sale of substantially all of its assets, pursuant to multiple Section 363 sales